0001181431-13-055216.txt : 20131025
0001181431-13-055216.hdr.sgml : 20131025
20131025204201
ACCESSION NUMBER: 0001181431-13-055216
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20130924
FILED AS OF DATE: 20131025
DATE AS OF CHANGE: 20131025
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: LA JOLLA PHARMACEUTICAL CO
CENTRAL INDEX KEY: 0000920465
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 330361285
STATE OF INCORPORATION: CA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4660 LA JOLLA VILLAGE DRIVE, SUITE 1070
CITY: SAN DIEGO
STATE: CA
ZIP: 92122
BUSINESS PHONE: 858-207-4264
MAIL ADDRESS:
STREET 1: 4660 LA JOLLA VILLAGE DRIVE, SUITE 1070
CITY: SAN DIEGO
STATE: CA
ZIP: 92122
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: TIDMARSH GEORGE F
CENTRAL INDEX KEY: 0001287235
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-24274
FILM NUMBER: 131171863
4/A
1
rrd393532.xml
FORM 4/A
X0306
4/A
2013-09-24
2013-10-11
0
0000920465
LA JOLLA PHARMACEUTICAL CO
LJPC
0001287235
TIDMARSH GEORGE F
4660 LA JOLLA VILLAGE DRIVE, SUITE 1070
SAN DIEGO
CA
92122
1
1
0
0
President, CEO and Sec'y
Common Stock
2013-09-24
4
A
0
1071429
0.07
A
69404300
D
This amendment is being filed solely to correct the number of securities acquired and beneficially owned following the reported transactions, which were reported incorrectly in the original Form 4 due to an administrative error.
The securities were acquired by the Reporting Person pursuant to a Securities Purchase Agreement made and entered into on September 24, 2013 by and among the Issuer, the Reporting Person and other purchasers.
By: /s/ George F. Tidmarsh
2013-10-25